x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Zumla, AlimuddinRemove Zumla, Alimuddin filter
- Ntoumi, FrancineRemove Ntoumi, Francine filter
- Kapata, NathanRemove Kapata, Nathan filter
Publication Date
Please choose a date range between 2020 and 2021.
Author
- Kock, Richard3
- Asogun, Danny2
- Azhar, Esam I2
- Bates, Matthew2
- Edwards, Sarah2
- Haider, Najmul2
- Hui, David S2
- Ippolito, Giuseppe2
- Mboera, Leonard2
- McHugh, Timothy D2
- Mfinanga, Sayoki2
- Mwaba, Peter2
- Nachega, Jean B2
- Abdel Hamid, Muzamil Mahdi1
- Abubakar, Aisha1
- Aklillu, Eleni1
- Al-Abri, Seif1
- Ansumana, Rashid1
- Arruda, Liã Bárbara1
- Blumberg, Lucille1
- Bockarie, Moses1
- Chakaya, Jeremiah1
Coronavirus (COVID-19) Collection
3 Results
- EditorialOpen Access
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
International Journal of Infectious DiseasesVol. 114p268–272Published online: December 1, 2021- Eskild Petersen
- Francine Ntoumi
- David S Hui
- Aisha Abubakar
- Laura D. Kramer
- Christina Obiero
- and others
Cited in Scopus: 100Nearly two years since the start of the SARS-CoV-2 pandemic, which has caused over 5 million deaths, the world continues to be on high COVID-19 alert. The World Health Organization (WHO), in collaboration with national authorities, public health institutions and scientists have been closely monitoring and assessing the evolution of SARS-CoV-2 since January 2020 (WHO 2021a; WHO 2021b). The emergence of specific SARS-CoV-2 variants were characterised as Variant of Interest (VOI) and Variant of Concern (VOC), to prioritise global monitoring and research, and to inform the ongoing global response to the COVID-19 pandemic. The WHO and its international sequencing networks continuously monitor SARS-CoV-2 mutations and inform countries about any changes that may be needed to respond to the variant, and prevent its spread where feasible. - EditorialOpen Access
COVID-19 travel restrictions and the International Health Regulations – Call for an open debate on easing of travel restrictions
International Journal of Infectious DiseasesVol. 94p88–90Published online: April 16, 2020- Eskild Petersen
- Brian McCloskey
- David S. Hui
- Richard Kock
- Francine Ntoumi
- Ziad A. Memish
- Nathan Kapata
- Esam I. Azhar
- Marjorie Pollack
- Larry C. Madoff
- Davidson H. Hamer
- Jean B. Nachega
- N. Pshenichnaya
- Alimuddin Zumla
Cited in Scopus: 24The COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) has made national governments worldwide to mandate several generic infection control measures such as physical distancing, self-isolation, and closure of non-essential shops, restaurants schools, among others. Some models suggest physical distancing would have to persist for 3 months to mitigate the peak effects on health systems and could be required on an intermittent basis for 12 to 18 months (Flaxman et al., 2020). - EditorialOpen Access
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future
International Journal of Infectious DiseasesVol. 93p233–236Published online: February 28, 2020- Nathan Kapata
- Chikwe Ihekweazu
- Francine Ntoumi
- Tajudeen Raji
- Pascalina Chanda-Kapata
- Peter Mwaba
- Victor Mukonka
- Matthew Bates
- John Tembo
- Victor Corman
- Sayoki Mfinanga
- Danny Asogun
- Linzy Elton
- Liã Bárbara Arruda
- Margaret J. Thomason
- Leonard Mboera
- Alexei Yavlinsky
- Najmul Haider
- David Simons
- Lara Hollmann
- Swaib A. Lule
- Francisco Veas
- Muzamil Mahdi Abdel Hamid
- Osman Dar
- Sarah Edwards
- Francesco Vairo
- Timothy D. McHugh
- Christian Drosten
- Richard Kock
- Giuseppe Ippolito
- Alimuddin Zumla
Cited in Scopus: 113Soon after the novel coronavirus, SARS-CoV-2 (2019-nCoV), was first identified in a cluster of patients with pneumonia (Li et al., 2020), in the Chinese city of Wuhan on 31 December 2019, rapid human to human transmission was anticipated (Hui et al., 2020). The fast pace of transmission is wreaking havoc and stirring media hype and public health concern (Ippolito et al., 2020) globally. When the World Health Organization (WHO) declared the disease, (now officially named COVID-19) a Public Health Emergency of International Concern (PHEIC) on 31st January 2020 (WHO, 2020a), the Director General Dr Tedros Ghebreyesus justified the decision by stating that WHOs greatest concern was the potential for the virus to spread to countries with weaker health systems.
